Equillium (EQ) Exchange Rate Effect (2019 - 2026)
Equillium (EQ) reported Exchange Rate Effect of $3000.0 for Q1 2026, up 400.0% year-over-year from $600.0 in Q1 2025, and down 92.31% quarter-over-quarter from $39000.0 in Q4 2025.
Equillium (EQ) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Equillium (EQ) has 8 years of Exchange Rate Effect data on file, last reported at $3000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $3000.0, up 400.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $51000.0 (up 176.12% YoY), and the FY2025 annual result was $47000.0, up 156.63% from the prior year.
- Exchange Rate Effect fell to $3000.0 in Q1 2026 per EQ's latest filing, from $39000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $48000.0 in Q3 2024 and troughed at -$133000.0 in Q4 2024.
- A 5-year average of -$8588.2 and a median of -$3000.0 in 2022 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2024 and 2026: Exchange Rate Effect sank 1800.0% in 2024, then surged 400.0% in 2026.
- A 5-year view of Exchange Rate Effect shows it stood at $31000.0 in 2022, then plunged by 148.39% to -$15000.0 in 2023, then slumped by 786.67% to -$133000.0 in 2024, then jumped by 129.32% to $39000.0 in 2025, then tumbled by 92.31% to $3000.0 in 2026.
- Business Quant data shows EQ's Exchange Rate Effect at $3000.0 in Q1 2026, $39000.0 in Q4 2025, and -$13000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 39,000.00 |
| Dec 31, 2025 | 39,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -133,000.00 |
| Dec 31, 2024 | -133,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | -17,000.00 |
| Mar 31, 2024 | -17,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Dec 31, 2023 | -15,000.00 |